SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed on October 26, 2022, by BioSig Technologies, Inc., a Delaware corporation. The report addresses corporate governance matters regarding the scheduling of the 2022 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report on a specific event and does not contain financial statements.
Material Changes
The Board of Directors changed the date of the 2022 Annual Meeting of Stockholders to December 20, 2022. This represents a change of more than 30 days from the anniversary of the 2021 Annual Meeting, triggering specific disclosure requirements for shareholder proposals and director nominations.
Guidance, Outlook, and Management Commentary
Management has established the following deadlines for shareholder actions:
- Record Date: October 31, 2022.
- Proposal Deadline: November 7, 2022, by 5:00 p.m. Eastern Time for inclusion in the proxy statement under Rule 14a-8.
- Compliance: Proposals must comply with SEC rules and the Company's amended and restated bylaws.
The filing contains no financial guidance, risk factors, or discussion of unusual items.
Key Facts for Investor Verification
- Verify the new Annual Meeting date of December 20, 2022.
- Confirm the November 7, 2022, deadline for submitting stockholder proposals.
- Note that the filing is signed by Kenneth L. Londoner, Executive Chairman.
- Recognize that this filing contains no financial performance data.